Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
Breaking Down HOOKIPA Pharma: 4 Analysts Share Their Views
細分HOOKIPA Pharma：4位分析師分享了他們的觀點
Across the recent three months, 4 analysts have shared their insights on HOOKIPA Pharma (NASDAQ:HOOK), expressing a variety of opinions spanning from bullish to bearish.
在最近三個月中，4位分析師分享了他們對HOOKIPA Pharma（納斯達克股票代碼：HOOK）的見解，表達了從看漲到看跌的各種觀點。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級，提供了對過去30天情緒變化的見解，並與前幾個月進行了比較以獲得整體視角。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.38, along with a high estimate of $6.50 and a low estimate of $5.00. This current average has decreased by 13.92% from the previous average price target of $6.25.
分析師提供了更深入的見解，確定了12個月的目標股價，平均目標價爲5.38美元，最高估計爲6.50美元，低估值爲5.00美元。目前的平均價格較之前的平均目標價6.25美元下降了13.92％。
Analyzing Analyst Ratings: A...
分析分析...
登入免費觀看全文
登入/註冊